320 likes | 1.11k Views
Pfizer . Zaneta Phean CIS 1055 Section 008 October 1, 2012. About pfizer. committed to applying science and our global resources to improve health and well-being at every stage of life
E N D
Pfizer ZanetaPhean CIS 1055 Section 008 October 1, 2012
About pfizer • committed to applying science and our global resources to improve health and well-being at every stage of life • provide access to safe, effective and affordable medicines and related health care services to the people who need them • leading portfolio of products and medicines that support wellness and prevention • treatment and cures for diseases across a broad range of therapeutic areas • industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer's disease and cancer • managed care organizations to world governments and non-governmental organizations • goal is to ensure that people everywhere have access to innovative treatments and quality health care Zaneta Phean Section 008
timeline Zaneta Phean Section 008
Cofounders Charles Pfizer Charles Erhart click arrow to meet the present Executive Leadership Team Zaneta Phean Section 008
Executive Leadership Team Zaneta Phean Section 008 click arrow to go back to previous page
Products • Pfizer product information is intended only for residents of the United States • Pfizer medicines help to treat and prevent a range of conditions from the most common to the most challenging for people around the world • Here is a list of a few Pfizer products people may be familiar with: • Advil Brands • Centrum Brands • Chapstick • Neosporin • Robitussin Zaneta Phean Section 008
Competitors • Merck & Co. Inc. • Novartis AG • Sanofi • Drug Manufacturers - Major Zaneta Phean Section 008
Recent News • September 21, 2012 — Pfizer Invites Public To View And Listen To Webcast Of October 30 Conference Call With Analysts • September 21, 2012 — ELIQUIS® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With NonvalvularAtrial Fibrillation • September 17, 2012 — Pfizer Announces Data For Investigational Compound Tofacitinib In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2012 Annual Meeting • September 17, 2012 — Pfizer To Present New Data in Lung And Kidney Cancers at The European Society For Medical Oncology 2012 Congress • September 13, 2012 — Pfizer and Waste Management Launch Online Pharmaceutical Disposal Guide • September 13, 2012 — Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference Zaneta Phean Section 008
For More Information • Call Us Customer Service and Product Inquiries: 1-800-TRY-FIRST (1-800-879-3477) Monday through Friday 8:00 a.m. to 8:00 p.m. EST Corporate Office: 1-212-733-2323 235 East 42nd Street New York, NY 10017 Frequently asked questions Send Email Zaneta Phean Section 008